Biotechnology Business

GenVec Reports Second Quarter 2007 Financial Results

Published in Healthcare Finance, Tax and Law Weekly, August 22nd, 2007

GenVec, Inc. (Nasdaq:GNVC) announced its financial results for the second quarter ended June 30, 2007. GenVec's net loss was $4.2 million or ($0.06) per share, compared to a net loss of $4.1 million or ($0.06) per share in the same prior year period.

For the six months ended June 30, 2007, GenVec's net loss was $10.2 million or ($0.14) per share, compared to a net loss of $8.2 million or ($0.13) per share for the six months ended June 30, 2006. Included in the net loss for the first six months of 2007 was stock-based compensation of $1,121,000 as compared to $583,000 for the same prior year period. GenVec ended the second quarter of 2007 with $29.4 million in cash and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2007-08-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry